Loading…

Arteriosclerosis Decreases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression on Liver Natural Killer Cells in Living Donor Liver Transplantation

•Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is critical for natural killer cell-mediated anti-tumor and anti-microbe killing.•TRAIL expression varies between individuals and is unpredictable.•Nutrition was an independent predictive factor for low TRAIL expression.•TRAIL expressi...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2023-05, Vol.55 (4), p.906-912
Main Authors: Imaoka, Kouki, Ohira, Masahiro, Bekki, Tomoaki, Sato, Koki, Imaoka, Yuki, Nakano, Ryosuke, Yano, Takuya, Sakai, Hiroshi, Tanimine, Naoki, Shimizu, Seiichi, Doskali, Marlen, Kuroda, Shintaro, Tahara, Hiroyuki, Ide, Kentaro, Kobayashi, Tsuyoshi, Tanaka, Yuka, Ohdan, Hideki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c432t-fc9ceeb328026c153059ee6aa0bd1a6d92d9548b7b9ed292ec266faa5aa474173
cites cdi_FETCH-LOGICAL-c432t-fc9ceeb328026c153059ee6aa0bd1a6d92d9548b7b9ed292ec266faa5aa474173
container_end_page 912
container_issue 4
container_start_page 906
container_title Transplantation proceedings
container_volume 55
creator Imaoka, Kouki
Ohira, Masahiro
Bekki, Tomoaki
Sato, Koki
Imaoka, Yuki
Nakano, Ryosuke
Yano, Takuya
Sakai, Hiroshi
Tanimine, Naoki
Shimizu, Seiichi
Doskali, Marlen
Kuroda, Shintaro
Tahara, Hiroyuki
Ide, Kentaro
Kobayashi, Tsuyoshi
Tanaka, Yuka
Ohdan, Hideki
description •Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is critical for natural killer cell-mediated anti-tumor and anti-microbe killing.•TRAIL expression varies between individuals and is unpredictable.•Nutrition was an independent predictive factor for low TRAIL expression.•TRAIL expression on liver natural killer cells was associated with atherosclerosis severity. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is critical for natural killer (NK) cell-mediated anti-tumor and anti-microbe killing. The TRAIL expression on the donor's liver NK cells from the liver perfusate after interleukin-2 stimulation varies between individuals and is unpredictable. This study aimed to clarify the risk factors for low TRAIL expression by analyzing perioperative donor characteristics. This retrospective study of living donor liver transplant (LDLT) donors between 2006 and 2022 was performed to analyze low TRAIL expression risk factors. Seventy-five donors who had undergone hepatectomy for LDLT were divided into 2 groups, low and high TRAIL, according to their TRAIL expression on liver NK cells, using median values. The low TRAIL group (N = 38) was older and had lower nutrition and a higher low-density lipoprotein/high-density lipoprotein (LDL/HDL) cholesterol ratio, related to arteriosclerosis, than the high TRAIL group (N = 37). In multivariate analysis, the geriatric nutritional risk index (GNRI) (odds ratio, 0.86; 95% CI, 0.76–0.94; P < .001) and LDL/HDL cholesterol ratio (odds ratio, 2.32; 95% CI, 1.10-4.86; P = .005) were independent predictive factors for low TRAIL expression on liver NK cells. Furthermore, the TRAIL expression of liver NK cells decreased in donors who already had atherosclerosis and in donors at risk of potentially developing atherosclerosis. The TRAIL expression on liver NK cells in donors had a strong relationship with atherosclerosis and GNRI. Atherosclerosis can reflect the TRAIL expression on liver NK cells.
doi_str_mv 10.1016/j.transproceed.2023.03.066
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2806072071</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S004113452300235X</els_id><sourcerecordid>2806072071</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-fc9ceeb328026c153059ee6aa0bd1a6d92d9548b7b9ed292ec266faa5aa474173</originalsourceid><addsrcrecordid>eNqNUV2LEzEUDaK4dfUvSPDJl6n5mMl0fCvtri4WBanP4U5yu6RMkzHJLPpz_Kdm2l3wUbgQLufcc3LvIeQdZ0vOuPpwXOYIPo0xGES7FEzIJSul1DOy4KtWVkIJ-ZwsGKt5xWXdXJFXKR1Z6UUtX5Ir2bKuYZwtyJ91zBhdSGbAGJJLdIsmIiRMdD-dQqRfS38GbsHkEKvvOEBGS9djGPMMVHfeTsb5e7pz9-Atvfk1RkzJBU9L7dwDFhXIU4SBfnFDMaIbHIZE3RmdJ7fBF6sLdX9ebgCfIReN1-TFAYaEbx7fa_Lj9ma_-Vztvn2626x3lamlyNXBdOUavRQrJpThjWRNh6gAWG85KNsJ2zX1qm_7Dq3oBBqh1AGgAajbmrfymry_6Ja7_pwwZX1yyZR_gscwJV2EFWsFa3mhfrxQ58ukiAc9RneC-FtzpueI9FH_G5GeI9KslFJl-O2jz9SfCvY0-pRJIWwvBCzbPjiMOhmH3qB1EU3WNrj_8fkLtW2t2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2806072071</pqid></control><display><type>article</type><title>Arteriosclerosis Decreases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression on Liver Natural Killer Cells in Living Donor Liver Transplantation</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Imaoka, Kouki ; Ohira, Masahiro ; Bekki, Tomoaki ; Sato, Koki ; Imaoka, Yuki ; Nakano, Ryosuke ; Yano, Takuya ; Sakai, Hiroshi ; Tanimine, Naoki ; Shimizu, Seiichi ; Doskali, Marlen ; Kuroda, Shintaro ; Tahara, Hiroyuki ; Ide, Kentaro ; Kobayashi, Tsuyoshi ; Tanaka, Yuka ; Ohdan, Hideki</creator><creatorcontrib>Imaoka, Kouki ; Ohira, Masahiro ; Bekki, Tomoaki ; Sato, Koki ; Imaoka, Yuki ; Nakano, Ryosuke ; Yano, Takuya ; Sakai, Hiroshi ; Tanimine, Naoki ; Shimizu, Seiichi ; Doskali, Marlen ; Kuroda, Shintaro ; Tahara, Hiroyuki ; Ide, Kentaro ; Kobayashi, Tsuyoshi ; Tanaka, Yuka ; Ohdan, Hideki</creatorcontrib><description>•Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is critical for natural killer cell-mediated anti-tumor and anti-microbe killing.•TRAIL expression varies between individuals and is unpredictable.•Nutrition was an independent predictive factor for low TRAIL expression.•TRAIL expression on liver natural killer cells was associated with atherosclerosis severity. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is critical for natural killer (NK) cell-mediated anti-tumor and anti-microbe killing. The TRAIL expression on the donor's liver NK cells from the liver perfusate after interleukin-2 stimulation varies between individuals and is unpredictable. This study aimed to clarify the risk factors for low TRAIL expression by analyzing perioperative donor characteristics. This retrospective study of living donor liver transplant (LDLT) donors between 2006 and 2022 was performed to analyze low TRAIL expression risk factors. Seventy-five donors who had undergone hepatectomy for LDLT were divided into 2 groups, low and high TRAIL, according to their TRAIL expression on liver NK cells, using median values. The low TRAIL group (N = 38) was older and had lower nutrition and a higher low-density lipoprotein/high-density lipoprotein (LDL/HDL) cholesterol ratio, related to arteriosclerosis, than the high TRAIL group (N = 37). In multivariate analysis, the geriatric nutritional risk index (GNRI) (odds ratio, 0.86; 95% CI, 0.76–0.94; P &lt; .001) and LDL/HDL cholesterol ratio (odds ratio, 2.32; 95% CI, 1.10-4.86; P = .005) were independent predictive factors for low TRAIL expression on liver NK cells. Furthermore, the TRAIL expression of liver NK cells decreased in donors who already had atherosclerosis and in donors at risk of potentially developing atherosclerosis. The TRAIL expression on liver NK cells in donors had a strong relationship with atherosclerosis and GNRI. Atherosclerosis can reflect the TRAIL expression on liver NK cells.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2023.03.066</identifier><identifier>PMID: 37095010</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Apoptosis ; Atherosclerosis ; Humans ; Killer Cells, Natural - metabolism ; Ligands ; Liver - pathology ; Liver Transplantation - adverse effects ; Living Donors ; Retrospective Studies ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Transplantation proceedings, 2023-05, Vol.55 (4), p.906-912</ispartof><rights>2023 Elsevier Inc.</rights><rights>Copyright © 2023 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-fc9ceeb328026c153059ee6aa0bd1a6d92d9548b7b9ed292ec266faa5aa474173</citedby><cites>FETCH-LOGICAL-c432t-fc9ceeb328026c153059ee6aa0bd1a6d92d9548b7b9ed292ec266faa5aa474173</cites><orcidid>0000-0001-8972-5777</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37095010$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Imaoka, Kouki</creatorcontrib><creatorcontrib>Ohira, Masahiro</creatorcontrib><creatorcontrib>Bekki, Tomoaki</creatorcontrib><creatorcontrib>Sato, Koki</creatorcontrib><creatorcontrib>Imaoka, Yuki</creatorcontrib><creatorcontrib>Nakano, Ryosuke</creatorcontrib><creatorcontrib>Yano, Takuya</creatorcontrib><creatorcontrib>Sakai, Hiroshi</creatorcontrib><creatorcontrib>Tanimine, Naoki</creatorcontrib><creatorcontrib>Shimizu, Seiichi</creatorcontrib><creatorcontrib>Doskali, Marlen</creatorcontrib><creatorcontrib>Kuroda, Shintaro</creatorcontrib><creatorcontrib>Tahara, Hiroyuki</creatorcontrib><creatorcontrib>Ide, Kentaro</creatorcontrib><creatorcontrib>Kobayashi, Tsuyoshi</creatorcontrib><creatorcontrib>Tanaka, Yuka</creatorcontrib><creatorcontrib>Ohdan, Hideki</creatorcontrib><title>Arteriosclerosis Decreases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression on Liver Natural Killer Cells in Living Donor Liver Transplantation</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>•Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is critical for natural killer cell-mediated anti-tumor and anti-microbe killing.•TRAIL expression varies between individuals and is unpredictable.•Nutrition was an independent predictive factor for low TRAIL expression.•TRAIL expression on liver natural killer cells was associated with atherosclerosis severity. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is critical for natural killer (NK) cell-mediated anti-tumor and anti-microbe killing. The TRAIL expression on the donor's liver NK cells from the liver perfusate after interleukin-2 stimulation varies between individuals and is unpredictable. This study aimed to clarify the risk factors for low TRAIL expression by analyzing perioperative donor characteristics. This retrospective study of living donor liver transplant (LDLT) donors between 2006 and 2022 was performed to analyze low TRAIL expression risk factors. Seventy-five donors who had undergone hepatectomy for LDLT were divided into 2 groups, low and high TRAIL, according to their TRAIL expression on liver NK cells, using median values. The low TRAIL group (N = 38) was older and had lower nutrition and a higher low-density lipoprotein/high-density lipoprotein (LDL/HDL) cholesterol ratio, related to arteriosclerosis, than the high TRAIL group (N = 37). In multivariate analysis, the geriatric nutritional risk index (GNRI) (odds ratio, 0.86; 95% CI, 0.76–0.94; P &lt; .001) and LDL/HDL cholesterol ratio (odds ratio, 2.32; 95% CI, 1.10-4.86; P = .005) were independent predictive factors for low TRAIL expression on liver NK cells. Furthermore, the TRAIL expression of liver NK cells decreased in donors who already had atherosclerosis and in donors at risk of potentially developing atherosclerosis. The TRAIL expression on liver NK cells in donors had a strong relationship with atherosclerosis and GNRI. Atherosclerosis can reflect the TRAIL expression on liver NK cells.</description><subject>Aged</subject><subject>Apoptosis</subject><subject>Atherosclerosis</subject><subject>Humans</subject><subject>Killer Cells, Natural - metabolism</subject><subject>Ligands</subject><subject>Liver - pathology</subject><subject>Liver Transplantation - adverse effects</subject><subject>Living Donors</subject><subject>Retrospective Studies</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqNUV2LEzEUDaK4dfUvSPDJl6n5mMl0fCvtri4WBanP4U5yu6RMkzHJLPpz_Kdm2l3wUbgQLufcc3LvIeQdZ0vOuPpwXOYIPo0xGES7FEzIJSul1DOy4KtWVkIJ-ZwsGKt5xWXdXJFXKR1Z6UUtX5Ir2bKuYZwtyJ91zBhdSGbAGJJLdIsmIiRMdD-dQqRfS38GbsHkEKvvOEBGS9djGPMMVHfeTsb5e7pz9-Atvfk1RkzJBU9L7dwDFhXIU4SBfnFDMaIbHIZE3RmdJ7fBF6sLdX9ebgCfIReN1-TFAYaEbx7fa_Lj9ma_-Vztvn2626x3lamlyNXBdOUavRQrJpThjWRNh6gAWG85KNsJ2zX1qm_7Dq3oBBqh1AGgAajbmrfymry_6Ja7_pwwZX1yyZR_gscwJV2EFWsFa3mhfrxQ58ukiAc9RneC-FtzpueI9FH_G5GeI9KslFJl-O2jz9SfCvY0-pRJIWwvBCzbPjiMOhmH3qB1EU3WNrj_8fkLtW2t2A</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Imaoka, Kouki</creator><creator>Ohira, Masahiro</creator><creator>Bekki, Tomoaki</creator><creator>Sato, Koki</creator><creator>Imaoka, Yuki</creator><creator>Nakano, Ryosuke</creator><creator>Yano, Takuya</creator><creator>Sakai, Hiroshi</creator><creator>Tanimine, Naoki</creator><creator>Shimizu, Seiichi</creator><creator>Doskali, Marlen</creator><creator>Kuroda, Shintaro</creator><creator>Tahara, Hiroyuki</creator><creator>Ide, Kentaro</creator><creator>Kobayashi, Tsuyoshi</creator><creator>Tanaka, Yuka</creator><creator>Ohdan, Hideki</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8972-5777</orcidid></search><sort><creationdate>202305</creationdate><title>Arteriosclerosis Decreases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression on Liver Natural Killer Cells in Living Donor Liver Transplantation</title><author>Imaoka, Kouki ; Ohira, Masahiro ; Bekki, Tomoaki ; Sato, Koki ; Imaoka, Yuki ; Nakano, Ryosuke ; Yano, Takuya ; Sakai, Hiroshi ; Tanimine, Naoki ; Shimizu, Seiichi ; Doskali, Marlen ; Kuroda, Shintaro ; Tahara, Hiroyuki ; Ide, Kentaro ; Kobayashi, Tsuyoshi ; Tanaka, Yuka ; Ohdan, Hideki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-fc9ceeb328026c153059ee6aa0bd1a6d92d9548b7b9ed292ec266faa5aa474173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Aged</topic><topic>Apoptosis</topic><topic>Atherosclerosis</topic><topic>Humans</topic><topic>Killer Cells, Natural - metabolism</topic><topic>Ligands</topic><topic>Liver - pathology</topic><topic>Liver Transplantation - adverse effects</topic><topic>Living Donors</topic><topic>Retrospective Studies</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Imaoka, Kouki</creatorcontrib><creatorcontrib>Ohira, Masahiro</creatorcontrib><creatorcontrib>Bekki, Tomoaki</creatorcontrib><creatorcontrib>Sato, Koki</creatorcontrib><creatorcontrib>Imaoka, Yuki</creatorcontrib><creatorcontrib>Nakano, Ryosuke</creatorcontrib><creatorcontrib>Yano, Takuya</creatorcontrib><creatorcontrib>Sakai, Hiroshi</creatorcontrib><creatorcontrib>Tanimine, Naoki</creatorcontrib><creatorcontrib>Shimizu, Seiichi</creatorcontrib><creatorcontrib>Doskali, Marlen</creatorcontrib><creatorcontrib>Kuroda, Shintaro</creatorcontrib><creatorcontrib>Tahara, Hiroyuki</creatorcontrib><creatorcontrib>Ide, Kentaro</creatorcontrib><creatorcontrib>Kobayashi, Tsuyoshi</creatorcontrib><creatorcontrib>Tanaka, Yuka</creatorcontrib><creatorcontrib>Ohdan, Hideki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Imaoka, Kouki</au><au>Ohira, Masahiro</au><au>Bekki, Tomoaki</au><au>Sato, Koki</au><au>Imaoka, Yuki</au><au>Nakano, Ryosuke</au><au>Yano, Takuya</au><au>Sakai, Hiroshi</au><au>Tanimine, Naoki</au><au>Shimizu, Seiichi</au><au>Doskali, Marlen</au><au>Kuroda, Shintaro</au><au>Tahara, Hiroyuki</au><au>Ide, Kentaro</au><au>Kobayashi, Tsuyoshi</au><au>Tanaka, Yuka</au><au>Ohdan, Hideki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Arteriosclerosis Decreases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression on Liver Natural Killer Cells in Living Donor Liver Transplantation</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2023-05</date><risdate>2023</risdate><volume>55</volume><issue>4</issue><spage>906</spage><epage>912</epage><pages>906-912</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><abstract>•Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is critical for natural killer cell-mediated anti-tumor and anti-microbe killing.•TRAIL expression varies between individuals and is unpredictable.•Nutrition was an independent predictive factor for low TRAIL expression.•TRAIL expression on liver natural killer cells was associated with atherosclerosis severity. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is critical for natural killer (NK) cell-mediated anti-tumor and anti-microbe killing. The TRAIL expression on the donor's liver NK cells from the liver perfusate after interleukin-2 stimulation varies between individuals and is unpredictable. This study aimed to clarify the risk factors for low TRAIL expression by analyzing perioperative donor characteristics. This retrospective study of living donor liver transplant (LDLT) donors between 2006 and 2022 was performed to analyze low TRAIL expression risk factors. Seventy-five donors who had undergone hepatectomy for LDLT were divided into 2 groups, low and high TRAIL, according to their TRAIL expression on liver NK cells, using median values. The low TRAIL group (N = 38) was older and had lower nutrition and a higher low-density lipoprotein/high-density lipoprotein (LDL/HDL) cholesterol ratio, related to arteriosclerosis, than the high TRAIL group (N = 37). In multivariate analysis, the geriatric nutritional risk index (GNRI) (odds ratio, 0.86; 95% CI, 0.76–0.94; P &lt; .001) and LDL/HDL cholesterol ratio (odds ratio, 2.32; 95% CI, 1.10-4.86; P = .005) were independent predictive factors for low TRAIL expression on liver NK cells. Furthermore, the TRAIL expression of liver NK cells decreased in donors who already had atherosclerosis and in donors at risk of potentially developing atherosclerosis. The TRAIL expression on liver NK cells in donors had a strong relationship with atherosclerosis and GNRI. Atherosclerosis can reflect the TRAIL expression on liver NK cells.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37095010</pmid><doi>10.1016/j.transproceed.2023.03.066</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-8972-5777</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2023-05, Vol.55 (4), p.906-912
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_2806072071
source ScienceDirect Freedom Collection 2022-2024
subjects Aged
Apoptosis
Atherosclerosis
Humans
Killer Cells, Natural - metabolism
Ligands
Liver - pathology
Liver Transplantation - adverse effects
Living Donors
Retrospective Studies
Tumor Necrosis Factor-alpha - metabolism
title Arteriosclerosis Decreases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression on Liver Natural Killer Cells in Living Donor Liver Transplantation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T10%3A32%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Arteriosclerosis%20Decreases%20Tumor%20Necrosis%20Factor-Related%20Apoptosis-Inducing%20Ligand%20Expression%20on%20Liver%20Natural%20Killer%20Cells%20in%20Living%20Donor%20Liver%20Transplantation&rft.jtitle=Transplantation%20proceedings&rft.au=Imaoka,%20Kouki&rft.date=2023-05&rft.volume=55&rft.issue=4&rft.spage=906&rft.epage=912&rft.pages=906-912&rft.issn=0041-1345&rft.eissn=1873-2623&rft_id=info:doi/10.1016/j.transproceed.2023.03.066&rft_dat=%3Cproquest_cross%3E2806072071%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c432t-fc9ceeb328026c153059ee6aa0bd1a6d92d9548b7b9ed292ec266faa5aa474173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2806072071&rft_id=info:pmid/37095010&rfr_iscdi=true